Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Phase III study of PhotoPoint therapy in AMD enrolling patients

Jan. 8, 1999

New hope for AMD sufferers: verteporfin proves effective and safe in TAP investigation

Jan. 8, 1999

Ophthalmic INS-365 to be developed by Inspire in collaboration with Santen

Jan. 5, 1999

AF1 promotes optic nerve regeneration in mouse model of glaucoma

Dec. 17, 1998

Medarex reports setback in phase III trial of MDX-RA

Dec. 15, 1998

FDA advisory committee will meet in January to review KeraVision Ring PMA

Dec. 9, 1998

Senju reports synthesis and evaluation of compounds with multiple pharmacological actions

Dec. 8, 1998

Photogen initiates development of ocular disease Rx; receives U.S. patents for technology

Dec. 7, 1998

Olopatadine combination more effective than loratadine monotherapy in allergic conjunctivitis

Nov. 27, 1998

CytoTherapeutics receives patent protection for ocular delivery of therapeutic substances

Nov. 25, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...